Industry News
Oxford spin-out sold for US$160 million
Oxford University spin-out company Oxitec, which is commercialising technology to control disease-carrying insects and pests, has been sold to synthetic biology specialist Intrexon Corporation for US$160 million. [ + ]
Monitoring the ocean's radioactive contamination with shellfish
A newly developed reference material, containing a mixture of freeze-dried, powdered shellfish, will help laboratories accurately measure radioactive contamination in seawater. [ + ]
IDT generic drug products to be commercialised in the US
US-based company ANI Pharmaceuticals has agreed to market and distribute up to 18 generic pharmaceutical products which have recently been acquired by IDT Australia. [ + ]
Puffed rice reveals patterns in compressed porous materials
An international research team has used puffed rice cereal to explain the patterns of movement in porous materials when compressed. [ + ]
Cancer screening pioneer joins Clinical Genomics
Clinical Genomics has announced clinical diagnostics pioneer Howard Chandler as its inaugural Emeritus Scientist. Chandler is the inventor of the patient-friendly 'brush' form of faecal immunochemical test (FIT). [ + ]
A re-usable system for launching satellites
The University of Queensland is developing a re-usable system that would make it cheaper and easier to launch satellites into space. [ + ]
What does Einstein have to do with space travel?
One hundred years after Albert Einstein first penned his theory of general relativity, Professor Geraint Lewis says we're only now starting to scratch the surface of what the theory predicts. [ + ]
Learn the basics of IP for business
IP Australia has released a video series to explain the six main types of intellectual property, both registered and unregistered, helping small business operators and innovators to understand what IP protection is available. [ + ]
Forums focused on bridging the commercialisation gap
This month will see the launch of a free forum series which is focused on education to help bridge the gap between research discovery and commercialisation. [ + ]
Stem cell trial for knee osteoarthritis underway
Regeneus shares jumped over 20% as the regenerative medicine company announced the first patient to be treated by Progenza, its mesenchymal stem cell therapy treatment for knee osteoarthritis. [ + ]
A new search for the origin of life
The ELSI Origins Network (EON) aims to advance our understanding of where, when and how life arose on Earth. [ + ]
Research collaboration to treat pulmonary fibrosis
Pharmaxis and Synairgen will develop a selective inhibitor to the LOXL2 enzyme to treat the lung disease idiopathic pulmonary fibrosis — a fatal condition that causes persistent and progressive scarring of the alveoli in the lungs. [ + ]
Former Telstra CEO to chair CSIRO board
Businessman and former Telstra CEO David Thodey has been appointed the new chair of the board of CSIRO for the next five years, Minister for Industry and Science Ian Macfarlane has announced. [ + ]
Inaugural Sydney Science Festival program released
The inaugural Sydney Science Festival will feature 70 science-based events, tours, workshops, exhibitions and activities held in 34 venues across the NSW capital. [ + ]
Adherium launches IPO prior to ASX listing
Digital health technology manufacturer Adherium is seeking to raise a maximum of $35 million in the lead-up to its listing on the ASX. [ + ]
